SEC 13F Intelligence

Cibc Private Wealth Group LLC / ABT

Cibc Private Wealth Group LLC’s Abbott Laboratories Position

Does Cibc Private Wealth Group LLC own Abbott Laboratories (ABT)? Yes — 3.93M shares worth $493M (+0.83% of its 13F portfolio) as of Q4 2025, down from 4.02M shares the prior filed quarter.

Position Value
$493M
Q4 2025
Shares
3.93M
% of Portfolio
+0.83%
Quarters Held
29
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $169MQ4 ’18Q1 ’19: $185MQ2 ’19: $192MQ3 ’19: $190MQ4 ’19: $203MQ4 ’19Q1 ’20: $289MQ2 ’20: $190MQ3 ’20: $428MQ4 ’20: $493MQ4 ’20Q1 ’21: $546MQ2 ’21: $472MQ3 ’21: $482MQ4 ’21: $586MQ4 ’21Q1 ’22: $502MQ2 ’22: $470MQ3 ’22: $426MQ4 ’22: $499MQ4 ’22Q1 ’23: $522MQ2 ’23: $574MQ3 ’23: $1.6BQ4 ’23: $546MQ4 ’23Q1 ’24: $546MQ2 ’24: $490MQ3 ’24: $546MQ4 ’24: $533MQ4 ’24Q1 ’25: $497MQ2 ’25: $560MQ3 ’25: $538MQ4 ’25: $493MQ4 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q4 20253.93M$493M+0.83%
Q3 20254.02M$538M+0.92%
Q2 20254.12M$560M+1.00%
Q1 20254.01M$497M+1.05%
Q4 20244.67M$533M+0.97%
Q3 20244.79M$546M+0.98%
Q2 20244.80M$490M+0.92%
Q1 20244.88M$546M+1.07%
Q4 20234.96M$546M+1.16%
Q3 202315.42M$1.6B+1.19%
Q2 20235.26M$574M+1.25%
Q1 20235.15M$522M+1.15%
Q4 20224.55M$499M+1.23%
Q3 20224.41M$426M+1.15%
Q2 20224.33M$470M+1.22%
Q1 20224.24M$502M+1.10%
Q4 20214.16M$586M+1.21%
Q3 20214.08M$482M+1.12%
Q2 20214.08M$472M+1.09%
Q1 20214.56M$546M+1.38%
Q4 20204.51M$493M+1.30%
Q3 20203.94M$428M+1.31%
Q2 20202.08M$190M+0.92%
Q1 20203.66M$289M+1.24%
Q4 20192.33M$203M+0.66%
Q3 20192.27M$190M+0.67%
Q2 20192.29M$192M+0.68%
Q1 20192.31M$185M+0.71%
Q4 20182.34M$169M+0.75%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Cibc Private Wealth Group LLC’s full portfolio or all institutional holders of ABT.